We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Jaundice in Newborns Linked to Autism

By HospiMedica International staff writers
Posted on 01 Nov 2010
Jaundice in full-term newborn infants is associated with an increased risk for autism and other psychological development disorders, according to a new study.

Researchers at Aarhus University (Denmark) conducted a population-based, follow-up study of the 733,826 children born alive in Denmark between 1994 and 2004 to explore the association between neonatal jaundice, autistic disorders, and other psychological development problems, and to study whether gestational age, parity, and season of birth influenced that association. More...
The data was analyzed to calculate hazard ratios (HRs).

The results showed that exposure to jaundice in neonates was associated with increased risk of disorders of psychological development for children born at term; the excess risk of developing a disorder in the spectrum of psychological development disorders after exposure to jaundice as a neonate was between 56% and 88%. The excess risk of infantile autism was 67%, and the risk was even higher if the child was conceived by a parous woman or was born between the months of October and March. The risk for infantile autism disappeared if the child was conceived by a primiparous woman, or was born between April and September. Similar risk patterns were found for the whole spectrum of autistic disorders. The study was published online on October 11, 2010, in Pediatrics.

"The knowledge that jaundice is associated with autism is one more clue to the puzzle towards finding its etiology,” said lead author Rikke Damkjaer Maimburg, M.P.H., Ph.D., and colleagues of the department of epidimiology. "If children with autism are genetically disposed to develop autism, there might be overlaps in the etiology between autism and jaundice; if exposure to jaundice can give autism, then we need to look at our treatment procedures.”

Neonatal jaundice is seen in 60% of term infants and, in most cases, resolves within the first week of life. Studies have shown that prolonged exposure to high bilirubin levels is neurotoxic and can cause lifelong developmental problems.

Related Links:

Aarhus University



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.